• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将替考拉宁转化为阳离子抗菌肽(AMP)。

Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP).

作者信息

Abdel Monaim Shimaa A H, Ramchuran Estelle J, El-Faham Ayman, Albericio Fernando, de la Torre Beatriz G

机构信息

Catalysis and Peptide Research Unit, School of Health Sciences, University of KwaZulu-Natal , Durban 4001, South Africa.

Department of Chemistry, College of Science, King Saud University , P.O. Box 2455, Riyadh 11451, Saudi Arabia.

出版信息

J Med Chem. 2017 Sep 14;60(17):7476-7482. doi: 10.1021/acs.jmedchem.7b00834. Epub 2017 Aug 23.

DOI:10.1021/acs.jmedchem.7b00834
PMID:28795806
Abstract

Teixobactin is a head to side chain cyclodepsipeptide that contains two positive charges. One is found in the cycle, as a result of the presence of the guanidino-unusual amino acid L-allo-End, while the other is at the N-terminal. Here we introduce 26 new Teixobactin analogues with an increasing number of positive charges. In an attempt to fine-tune the biological activity of Teixobactin, we examined the effect of cationicity on the SAR of these analogues. The maximum number of positive charges to maintain the activity are three to four. Analogues with five positive charges show the lowest activity.

摘要

替考拉宁是一种含有两个正电荷的头对侧链环缩肽。其中一个正电荷存在于环中,这是由于胍基不寻常的氨基酸L-别异亮氨酸的存在,而另一个正电荷位于N端。在此,我们引入了26种带正电荷数量递增的新型替考拉宁类似物。为了微调替考拉宁的生物活性,我们研究了阳离子性对这些类似物构效关系的影响。维持活性的正电荷最大数量为三到四个。带有五个正电荷的类似物活性最低。

相似文献

1
Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP).将替考拉宁转化为阳离子抗菌肽(AMP)。
J Med Chem. 2017 Sep 14;60(17):7476-7482. doi: 10.1021/acs.jmedchem.7b00834. Epub 2017 Aug 23.
2
Investigation of the N-Terminus Amino Function of Arg-Teixobactin.研究 Arg-Teixobactin 的 N 端氨基功能。
Molecules. 2017 Sep 28;22(10):1632. doi: 10.3390/molecules22101632.
3
Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine.泰妙菌素类似物的合成及非等排取代延胡索氨酸的抗菌研究。
Bioorg Med Chem. 2018 Mar 1;26(5):1062-1068. doi: 10.1016/j.bmc.2018.01.016. Epub 2018 Feb 1.
4
Synthesis and biological evaluation of novel teixobactin analogues.新型替考拉宁类似物的合成与生物学评价
Org Biomol Chem. 2017 Oct 25;15(41):8755-8760. doi: 10.1039/c7ob02169k.
5
Chemistry and Biology of Teixobactin.泰妙菌素的化学与生物学。
Chemistry. 2018 Apr 11;24(21):5406-5422. doi: 10.1002/chem.201704167. Epub 2017 Dec 12.
6
Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres.通过用其电子等排体取代L-别恩杜拉西定合成抗耐甲氧西林金黄色葡萄球菌(MRSA)的强效替考拉宁类似物。
Chem Commun (Camb). 2017 Jul 6;53(55):7788-7791. doi: 10.1039/c7cc04021k.
7
Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study.泰妙菌素作为一个支架用于无限新的抗菌肽:SAR 研究。
Bioorg Med Chem. 2018 Jun 1;26(10):2788-2796. doi: 10.1016/j.bmc.2017.09.040. Epub 2017 Sep 30.
8
Synthesis and structure-activity relationship of teixobactin analogues via convergent Ser ligation.通过收敛性丝氨酸连接法合成替考拉宁类似物及其构效关系
Bioorg Med Chem. 2017 Sep 15;25(18):4990-4995. doi: 10.1016/j.bmc.2017.04.039. Epub 2017 Apr 29.
9
Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.替考拉宁及其类似物:抗生素发现中的新希望。
ACS Infect Dis. 2017 Oct 13;3(10):688-690. doi: 10.1021/acsinfecdis.7b00108. Epub 2017 Aug 3.
10
Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.开发针对耐药菌的等效替考拉宁类似物,并发现脂质 II 与替考拉宁之间的疏水相互作用。
J Med Chem. 2018 Apr 26;61(8):3409-3421. doi: 10.1021/acs.jmedchem.7b01241. Epub 2018 Apr 13.

引用本文的文献

1
Modulating Copper(II) Coordination and Antimicrobial Activity: Effects of d-Amino Acid Substitution and Modification in Human Saliva MUC7 Peptide.调节铜(II)配位和抗菌活性:d-氨基酸取代及人唾液粘蛋白MUC7肽修饰的影响
Inorg Chem. 2025 Mar 31;64(12):6365-6377. doi: 10.1021/acs.inorgchem.5c00438. Epub 2025 Mar 19.
2
The Antimicrobial Peptide Capitellacin: Chemical Synthesis of Analogues to Probe the Role of Disulphide Bridges and Their Replacement with Vinyl Sulphides.抗菌肽 Capitellacin:类似物的化学合成以探究二硫键的作用及其被乙烯基硫醚取代的情况
Antibiotics (Basel). 2024 Jul 2;13(7):615. doi: 10.3390/antibiotics13070615.
3
Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products.
天然产物结构-活性关系研究方法的进展、机遇与挑战。
Nat Prod Rep. 2024 Oct 17;41(10):1543-1578. doi: 10.1039/d4np00009a.
4
1,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization.1,3,5-三嗪作为构建新型抗菌肽树状大分子的分支连接剂:合成与生物学特性。
Int J Mol Sci. 2024 May 28;25(11):5883. doi: 10.3390/ijms25115883.
5
Characteristics and therapeutic applications of antimicrobial peptides.抗菌肽的特性与治疗应用
Biophys Rev (Melville). 2021 Feb 19;2(1):011301. doi: 10.1063/5.0035731. eCollection 2021 Mar.
6
New Teixobactin Analogues with a Total Lactam Ring.具有完整内酰胺环的新型替考拉宁类似物。
ACS Med Chem Lett. 2023 Nov 14;14(12):1827-1832. doi: 10.1021/acsmedchemlett.3c00435. eCollection 2023 Dec 14.
7
Cyclic Peptides in Pipeline: What Future for These Great Molecules?处于研发阶段的环肽:这些伟大分子的未来如何?
Pharmaceuticals (Basel). 2023 Jul 12;16(7):996. doi: 10.3390/ph16070996.
8
Emerging peptide antibiotics with therapeutic potential.具有治疗潜力的新型肽类抗生素。
Med Drug Discov. 2021 Mar;9:100078. doi: 10.1016/j.medidd.2020.100078. Epub 2020 Dec 30.
9
Spotlight on the Selected New Antimicrobial Innate Immune Peptides Discovered During 2015-2019.聚焦2015 - 2019年期间发现的精选新型抗菌天然免疫肽。
Curr Top Med Chem. 2020;20(32):2984-2998. doi: 10.2174/1568026620666201022143625.
10
Morphing of Amphipathic Helices to Explore the Activity and Selectivity of Membranolytic Antimicrobial Peptides.两亲性螺旋的变形研究以探索膜裂解抗菌肽的活性和选择性。
Biochemistry. 2020 Oct 6;59(39):3772-3781. doi: 10.1021/acs.biochem.0c00565. Epub 2020 Sep 16.